Clinical Trial Update: Long Term Follow-up (LTFU) of Subjects Who Received SB-318, SB-913, or SB-FIX

View source ↗

Summary

Long-term follow-up study update for subjects treated with Sangamo's SB-318, SB-913, or SB-FIX, evaluating ongoing outcomes in hemophilia B and mucopolysacchari…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia
• Mucopolysaccharidosis Type
• Mucopolysaccharidosis Type Ii

Drugs mentioned

• SB-318
• SB-913
• SB-FIX

Snippet

Sponsor: Sangamo Therapeutics | Conditions: Hemophilia B, Mucopolysaccharidosis I | Status: ACTIVE_NOT_RECRUITING